Movano Inc.'s Initial Public Offering
March 23, 2021Movano Inc. Appoints Medtech Industry Veteran John Mastrototaro, PhD, as CEO
As the pioneer of the first FDA-approved continuous glucose monitor, Dr. Mastrototaro will be integral in advancing the development and regulatory process of the Company
March 25, 2021Movano Inc. Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option
PLEASANTON, CA / ACCESSWIRE / March 25, 2021 / Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health
March 25, 2021Investor Relations
Transfer Agent
Philadelphia Stock Transfer, Inc.
2320 Haverford Rd.
Suite 230
Ardmore, PA 19003
